How to Leverage Data and Technology to Promote Clinical Trial Diversity

H1’s Director of Product Marketing, Alexandra Moens, discusses the importance of promoting diversity and how it applies to clinical trials, why the time is now for companies to take action steps to ensure a more diverse patient population, and how H1 is uniquely positioned to help companies harness existing data to significantly enhance their diversity efforts.

Site Technology: The Future is Free

Ask any study site: Sponsors are looking to lower costs at sites, while requiring higher quality and faster performance. To achieve this, many sponsors are expecting sites to deploy new technologies, but study sites face challenges in funding expensive platforms such as CTMS, eSource systems and eReg binders.